Literature DB >> 18718936

A mouse model for congenital myasthenic syndrome due to MuSK mutations reveals defects in structure and function of neuromuscular junctions.

Frédéric Chevessier1, Emmanuelle Girard, Jordi Molgó, Sönke Bartling, Jeanine Koenig, Daniel Hantaï, Veit Witzemann.   

Abstract

In the muscle-specific tyrosine kinase receptor gene MUSK, a heteroallelic missense and a null mutation were identified in a patient suffering from a congenital myasthenic syndrome (CMS). We generated one mouse line carrying the homozygous missense mutation V789M in musk (musk(V789M/V789M) mice) and a second hemizygous line, resembling the patient genotype, with the V789M mutation on one allele and an allele lacking the kinase domain (musk(V789M/-) mice). We report here that musk(V789M/V789M) mice present no obvious abnormal phenotype regarding weight, muscle function and viability. In contrast, adult musk(V789M/-) mice suffer from severe muscle weakness, exhibit shrinkage of pelvic and scapular regions and hunchback. Musk(V789M/-) diaphragm develops less force upon direct or nerve-induced stimulation. A profound tetanic fade is observed following nerve-evoked muscle contraction, and fatigue resistance is severely impaired upon a train of tetanic nerve stimulations. Electrophysiological measurements indicate that fatigable muscle weakness is due to impaired neurotransmission as observed in a patient suffering from a CMS. The diaphragm of adult musk(V789M/-) mice exhibits pronounced changes in endplate architecture, distribution and innervation pattern. Thus, the missense mutation V789M in MuSK acts as a hypomorphic mutation and leads to insufficiency in MuSK function in musk(V789M/-) mutants. These mutant mice represent valuable models for elucidating the roles of MuSK for synapse formation, maturation and maintenance as well as for studying the pathophysiology of a CMS due to MuSK mutations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18718936     DOI: 10.1093/hmg/ddn251

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  16 in total

1.  Measuring Neuromuscular Junction Functionality.

Authors:  Emanuele Rizzuto; Simona Pisu; Carmine Nicoletti; Zaccaria Del Prete; Antonio Musarò
Journal:  J Vis Exp       Date:  2017-08-06       Impact factor: 1.355

Review 2.  Current status of the congenital myasthenic syndromes.

Authors:  Andrew G Engel
Journal:  Neuromuscul Disord       Date:  2011-11-21       Impact factor: 4.296

Review 3.  Skeletal muscle in motor neuron diseases: therapeutic target and delivery route for potential treatments.

Authors:  Luc Dupuis; Andoni Echaniz-Laguna
Journal:  Curr Drug Targets       Date:  2010-10       Impact factor: 3.465

Review 4.  Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment.

Authors:  Andrew G Engel; Xin-Ming Shen; Duygu Selcen; Steven M Sine
Journal:  Lancet Neurol       Date:  2015-04       Impact factor: 44.182

5.  Ephexin1 is required for structural maturation and neurotransmission at the neuromuscular junction.

Authors:  Lei Shi; Busma Butt; Fanny C F Ip; Ying Dai; Liwen Jiang; Wing-Ho Yung; Michael E Greenberg; Amy K Y Fu; Nancy Y Ip
Journal:  Neuron       Date:  2010-01-28       Impact factor: 17.173

6.  Mutations in MUSK causing congenital myasthenic syndrome impair MuSK-Dok-7 interaction.

Authors:  Ricardo A Maselli; Juan Arredondo; Orla Cagney; Jarae J Ng; Jennifer A Anderson; Colette Williams; Bae J Gerke; Betty Soliven; Robert L Wollmann
Journal:  Hum Mol Genet       Date:  2010-04-06       Impact factor: 6.150

7.  LRP4 is critical for neuromuscular junction maintenance.

Authors:  Arnab Barik; Yisheng Lu; Anupama Sathyamurthy; Andrew Bowman; Chengyong Shen; Lei Li; Wen-cheng Xiong; Lin Mei
Journal:  J Neurosci       Date:  2014-10-15       Impact factor: 6.167

8.  A Role of Lamin A/C in Preventing Neuromuscular Junction Decline in Mice.

Authors:  Nannan Gao; Kai Zhao; Yu Cao; Xiao Ren; Hongyang Jing; Guanglin Xing; Wen-Cheng Xiong; Lin Mei
Journal:  J Neurosci       Date:  2020-08-17       Impact factor: 6.167

9.  Myostatin Inhibition-Induced Increase in Muscle Mass and Strength Was Amplified by Resistance Exercise Training, and Dietary Essential Amino Acids Improved Muscle Quality in Mice.

Authors:  Jiwoong Jang; Sanghee Park; Yeongmin Kim; Jiyeon Jung; Jinseok Lee; Yewon Chang; Sang Pil Lee; Bum-Chan Park; Robert R Wolfe; Cheol Soo Choi; Il-Young Kim
Journal:  Nutrients       Date:  2021-04-29       Impact factor: 5.717

10.  Congenital Myasthenic Syndromes with Predominant Limb Girdle Weakness.

Authors:  Teresinha Evangelista; Mike Hanna; Hanns Lochmüller
Journal:  J Neuromuscul Dis       Date:  2015-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.